Evidence map›Paper›PMID 35941179›Full record

ArticleNature communications2022

Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.

Caterina Bartolacci, Cristina Andreani, Gonçalo Vale, Stefano Berto, Margherita Melegari, Anna Colleen Crouch, Dodge L Baluya, George Kemble, Kurt Hodges, Jacqueline Starrett and 12 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Caterina Bartolacci *Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45219, USA.
Cristina Andreani *Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45219, USA.ORCID http://orcid.org/0000-0003-3245-670X
Gonçalo ValeCenter for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID http://orcid.org/0000-0003-1104-0289
Stefano BertoDepartment of Neuroscience, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID http://orcid.org/0000-0001-9028-9458
Margherita MelegariDepartment of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45219, USA.
Anna Colleen CrouchDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dodge L BaluyaTissue Imaging and Proteomics Laboratory, Washington State University, Pullman, WA, 99164, USA.
George KembleSagimet Biosciences, San Mateo, CA, 94402, USA.
Kurt HodgesDepartment of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH, 45219, USA.
Jacqueline StarrettYale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Katerina PolitiYale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Sandra L StarnesDepartment of Surgery, Division of Thoracic Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, 45219, USA.
Daniele LorenziniDepartment of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, via Venezian 1, 20133, Milan, Italy.
Maria Gabriela RasoDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-2105-5556
Luisa M Solis SotoDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1253-630X
Carmen BehrensDepartment of Thoracic H&N Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Humam KadaraDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Boning GaoHamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID http://orcid.org/0000-0002-1382-395X
Ignacio I WistubaDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
John D MinnaHamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID http://orcid.org/0000-0002-7776-0767
Jeffrey G McDonaldCenter for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID http://orcid.org/0000-0003-1570-4142
Pier Paolo ScaglioniDepartment of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45219, USA. Scaglipr@ucmail.uc.edu.ORCID http://orcid.org/0000-0002-6036-5138
The University of Texas MD Anderson Cancer Center · USThe University of Texas Southwestern Medical Center · USUniversity of Cincinnati Medical Center · USYale Cancer Center · USFondazione IRCCS Istituto Nazionale dei Tumori · ITUniversity of Cincinnati · USWashington State University · US

Funding

Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancerR01CA259845 · NCI · UNIVERSITY OF CINCINNATI · PI PIER Paolo SCAGLIONI · 2022 to 2026
$2.0M
NCI NIH HHS R01 CA259845
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35941179
PMCPMC9360441
OpenAlexW4290672693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.